These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25239267)

  • 1. Antiepileptic drugs for the treatment of agitation and aggression in dementia: do they have a place in therapy?
    Gallagher D; Herrmann N
    Drugs; 2014 Oct; 74(15):1747-55. PubMed ID: 25239267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newer antiepileptic drugs in the management of agitation/aggression in patients with dementia or developmental disability.
    Guay DR
    Consult Pharm; 2007 Dec; 22(12):1004-34. PubMed ID: 18198960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia.
    Sommer OH; Aga O; Cvancarova M; Olsen IC; Selbaek G; Engedal K
    Dement Geriatr Cogn Disord; 2009; 27(2):155-63. PubMed ID: 19182483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anticonvulsant mood stabilizers in the treatment of behavioral and psychological symptoms of dementia (BPSD)].
    Pinheiro D
    Encephale; 2008 Sep; 34(4):409-15. PubMed ID: 18922244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
    Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
    Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis.
    Gobbi G; Gaudreau PO; Leblanc N
    J Clin Psychopharmacol; 2006 Oct; 26(5):467-73. PubMed ID: 16974186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia.
    Tariot PN; Erb R; Podgorski CA; Cox C; Patel S; Jakimovich L; Irvine C
    Am J Psychiatry; 1998 Jan; 155(1):54-61. PubMed ID: 9433339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia.
    Davies SJ; Burhan AM; Kim D; Gerretsen P; Graff-Guerrero A; Woo VL; Kumar S; Colman S; Pollock BG; Mulsant BH; Rajji TK
    J Psychopharmacol; 2018 May; 32(5):509-523. PubMed ID: 29338602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal from controlled carbamazepine therapy followed by further carbamazepine treatment in patients with dementia.
    Tariot PN; Jakimovich LJ; Erb R; Cox C; Lanning B; Irvine C; Podgorski CA
    J Clin Psychiatry; 1999 Oct; 60(10):684-9. PubMed ID: 10549685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of anticonvulsants in treating agitated demented elderly patients.
    Grossman F
    Pharmacotherapy; 1998; 18(3):600-6. PubMed ID: 9620110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.
    Marson AG; Appleton R; Baker GA; Chadwick DW; Doughty J; Eaton B; Gamble C; Jacoby A; Shackley P; Smith DF; Tudur-Smith C; Vanoli A; Williamson PR
    Health Technol Assess; 2007 Oct; 11(37):iii-iv, ix-x, 1-134. PubMed ID: 17903391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
    Lancet Neurol; 2018 Jun; 17(6):530-538. PubMed ID: 29680205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ;
    Neurology; 2004 Apr; 62(8):1261-73. PubMed ID: 15111660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease.
    Herrmann N; Lanctôt KL; Rothenburg LS; Eryavec G
    Dement Geriatr Cogn Disord; 2007; 23(2):116-9. PubMed ID: 17148938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment of symptomatic behaviors in dementia.
    Schneider LS; Gleason R
    J Geriatr Psychiatry Neurol; 1989; 2(1):57-8. PubMed ID: 2742735
    [No Abstract]   [Full Text] [Related]  

  • 16. The efficacy and safety of newer anticonvulsants in patients with dementia.
    Dolder CR; Nealy KL
    Drugs Aging; 2012 Aug; 29(8):627-37. PubMed ID: 22734626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Tolerability of Antiepileptic Drugs in Patients with Focal Epilepsy: Systematic Review and Network Meta-analyses.
    Campos MS; Ayres LR; Morelo MR; Marques FA; Pereira LR
    Pharmacotherapy; 2016 Dec; 36(12):1255-1271. PubMed ID: 27779771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates.
    Marcinkowska M; Śniecikowska J; Fajkis N; Paśko P; Franczyk W; Kołaczkowski M
    CNS Drugs; 2020 Mar; 34(3):243-268. PubMed ID: 32052375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haloperidol for agitation in dementia.
    Lonergan E; Luxenberg J; Colford J
    Cochrane Database Syst Rev; 2001; (4):CD002852. PubMed ID: 11687166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of antiepileptic drug use during pregnancy over a period of 12 years in Spain. Efficacy of the newer antiepileptic drugs lamotrigine, levetiracetam, and oxcarbazepine.
    Martinez Ferri M; Peña Mayor P; Perez López-Fraile I; Escartin Siquier A; Martin Moro M; Forcadas Berdusan M;
    Neurologia (Engl Ed); 2018 Mar; 33(2):78-84. PubMed ID: 27452623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.